ERFSF:OTC-Eurofins Scientific SE (USD)

COMMON STOCK | Diagnostics & Research | OTC

Last Closing Price

USD 124.52

Change

0.00 (0.00)%

Market Cap

USD 24.15B

Volume

56.00

Avg Analyst Target

N/A

Avg User Target

USD
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

About

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of approximately 200,000 analytical methods for evaluating the safety, identity, composition, authenticity, origin, traceability, and purity of biological substances and products, as well as for clinical diagnostic. It provides agroscience, agro testing, assurance, biopharma, clinical diagnostics, consumer product testing, cosmetics and personal care, environment testing, food and feed testing, forensic, genomic, maritime, materials and engineering, technologies, and REACH services. The company serves clients from a range of industries, including the pharmaceutical, food, environmental, and clinical diagnostics sectors. It operates approximately 800 laboratories in 50 countries. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-10-16 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
SMMNY Siemens Healthineers AG

N/A

USD75.00B 36.58 20.94
SEMHF Siemens Healthineers AG

N/A

USD73.28B 35.55 20.94
LZAGY Lonza Group Ltd

N/A

USD58.10B 76.43 86.23
LZAGF Lonza Group Ltd

N/A

USD58.02B 76.15 86.23
RYLPF Koninklijke Philips N.V

N/A

USD40.11B 30.59 16.43
SSMXF Sysmex Corporation

N/A

USD26.42B 77.59 0.30
SSMXY Sysmex Corporation

N/A

USD26.09B 76.62 0.30
BMXMF bioMérieux S.A

N/A

USD13.74B 23.42 14.74
DSRLF DiaSorin S.p.A

N/A

USD11.36B 32.02 25.14
MRCHF H.U. Group Holdings Inc

N/A

USD1.49B 6.23 0.04

ETFs Containing ERFSF

Symbol Name Weight Mer Price(Change) Market Cap
MXU:CA Mackenzie Maximum Diversi.. 0.00 % 0.55 %

N/A

USD0.08B
IDLB Invesco FTSE Internationa.. 0.00 % 0.45 %

N/A

USD7.71M
PQIN PGIM ETF Trust - PGIM QMA.. 0.00 % 0.29 %

N/A

USD0.04B
IEFS:LSE iShares Edge MSCIope Size.. 0.00 % 0.25 %

N/A

USD0.03B
IQQM:F iShares Public Limited Co.. 0.00 % 0.40 %

N/A

USD0.58B
CEMT:XETRA iShares Edge MSCI Europe .. 0.00 % 0.25 %

N/A

USD0.03B
EXSD:XETRA iShares STOXX Europe Mid .. 0.00 % 0.20 %

N/A

USD5,934.00B
IQQM:XETRA iShares Public Limited Co.. 0.00 % 0.40 %

N/A

USD0.59B
FICS First Trust International.. 0.00 % 0.70 %

N/A

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Diagnostics & Research)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 51.12% 83% B 76% C
Dividend Return 0.99% 60% D- 13% F
Total Return 52.11% 83% B 75% C
Trailing 12 Months  
Capital Gain 1,373.52% 100% A+ 97% A+
Dividend Return 9.70% 90% A- 85% B
Total Return 1,383.22% 100% A+ 97% A+
Trailing 5 Years  
Capital Gain 2,619.14% 97% A+ 94% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 2,619.14% 97% A+ 94% A
Average Annual (5 Year Horizon)  
Capital Gain 373.91% 95% A 91% A-
Dividend Return 0.97% 54% F 26% F
Total Return 374.87% 95% A 91% A-
Risk Return Profile  
Volatility (Standard Deviation) 685.87% 7% F 12% F
Risk Adjusted Return 54.66% 71% C- 78% C+
Market Capitalization 24.15B 87% B+ 94% A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Diagnostics & Research)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 26.08 46% F 28% F
Price/Book Ratio 5.03 57% F 25% F
Price / Cash Flow Ratio 19.74 22% F 11% F
EV/EBITDA 13.96 45% F 24% F
Management Effectiveness  
Return on Equity 22.72% 89% B+ 88% B+
Return on Invested Capital 10.75% 64% D 74% C
Return on Assets 10.49% 94% A 93% A
Debt to Equity Ratio 67.81% 13% F 28% F
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 0.60 55% F 62% D-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters then its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.